ISSN: 2161-0681

Journal of Clinical & Experimental Pathology
Open Access

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
Google Scholar citation report
Citations : 2975

Journal of Clinical & Experimental Pathology received 2975 citations as per Google Scholar report

Journal of Clinical & Experimental Pathology peer review process verified at publons
Indexed In
  • Index Copernicus
  • Google Scholar
  • Sherpa Romeo
  • Open J Gate
  • Genamics JournalSeek
  • JournalTOCs
  • Cosmos IF
  • Ulrich's Periodicals Directory
  • RefSeek
  • Directory of Research Journal Indexing (DRJI)
  • Hamdard University
  • EBSCO A-Z
  • OCLC- WorldCat
  • Publons
  • Geneva Foundation for Medical Education and Research
  • Euro Pub
  • ICMJE
  • world cat
  • journal seek genamics
  • j-gate
  • esji (eurasian scientific journal index)
Share This Page

Evaluating the capacity of novel image analysis algorithms in estimating prostate cancer patient outcomes

4th International Conference and Exhibition on Pathology

Patrick Jackman and William Watson

ScientificTracks Abstracts-Workshop: J Clin Exp Pathol

DOI: 10.4172/2161-0681.S1.016

Abstract
There are a number of dilemmas in the diagnosis and treatment of prostate cancer. Current strategies result in over treatment of indolent disease due to their inability to determine if a tumor will progress. Image analysis offers a mechanism for objective, reproducible and repeatable biopsy interpretation and also the extraction of novel biomarkers imperceptible to the human eye. Thus, adding further information to stratify patients into appropriate treatments. The Irish Prostate Cancer Research Consortium cohort was used for re-interpreting digital colour images of prostate tissue sections. The patient outcomes of this cohort are known (Indolent, Significant or Aggressive) as well clinical information (PSA, family history, DRE, needle biopsy Gleason Score, Age). Novel image tissue features of entropy and symmetric wavelets were calculated on local and overall tissue level. Similarly cell nuclei size and distributions were calculated along with luminal and stromal distributions. Using k-Nearest Neighbors and Neural Network models correct classification rates of patient outcomes based on clinical datasets (53%), image datasets (49%) and the merged datasets (56%) were computed for Indolent, Significant or Aggressive disease. Similarly patient outcomes based on clinical datasets (79%), image datasets (77%) and the merged datasets (84%) were computed for Indolent or non-Indolent disease. Thus, indicating that the novel image features are synergetic with clinical data in separating patients with or without a significant cancer. These image features add value to the current clinical features and could be used to reduce the over treatment of prostate cancer and increase the quality of life of these patients.
Biography
Patrick Jackman pursued research with the aim to find alternative solutions to challenging research questions. He has published 15 papers in high impact journals, 2 book chapters and 7 conference papers. In 2008 he was awarded the Armaund Blanc young researcher of the year award in advance of the awarding of his PhD in 2009. He has worked in commercially based research in the University of Manchester and his current role is Senior Research Fellow: FASTPATH: Fast-Tracking Pathology via Automated Image Analysis and High-Performance Computing: Application to Prostate Cancer Diagnostics (Marie Curie IAPP (FP7)), University College Dublin, Ireland.
Top